📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-30 00:05
16 analysed today
16
Today
146,666
All-time analysed
42,321
Positive
6,565
Negative
89,283
Neutral
8,429
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
68 announcements match the current filters (relevance ≥ 5).
Deepa Jewellers Q1 FY27 Revenue Up 39% YoY to ₹431.1 Cr, PAT Rises 27% to ₹26.8 Cr
Deepa Jewellers released its Q1 FY27 investor presentation following results, posting revenue from operations of ₹431.1 crore (INR 4,311 Mn), up 39.0% YoY. EBITDA grew 33.9% YoY to ₹38.7 crore with EBITDA margins contracting slightly by 34 bps to 8.98% due to karigar hiring costs. Net profit rose 27.0% YoY to ₹26.8 crore, delivering a diluted EPS of ₹3.26. The company is transitioning from an outsourced model to an in-house manufacturing facility (6,696 sq ft in Hyderabad) and expanding its South India distribution footprint.
Confidence: HIGH
What changedDeepa Jewellers released its detailed Q1 FY27 investor presentation detailing segmental metrics, manufacturing transition, and regional expansion.
Why it mattersDemonstrates strong topline growth (+39% YoY) and outlines a structural shift towards in-house manufacturing and direct regional distribution, which could protect gross margins long term.
Q1 FY27 Operational Revenue: INR 4,311 MnQ1 FY27 EBITDA: INR 387 MnQ1 FY27 PAT: INR 268 MnHyderabad Facility Size: 6,696 sq ftCustomer Count: 373
📅 Short termThe market will digest the strong 39% YoY revenue jump against a 20.3% QoQ contraction, which management attributes to jewellery industry seasonality.
📈 Long termTransition to dedicated in-house manufacturing coupled with expansion into Tamil Nadu and Karnataka could structurally improve margin retention and reduce karigar dependency.
⚠ Risk flags
- Working capital intensive business model with increasing trade receivables (INR 2,523 Mn in FY26)
- Higher finance costs from increased debt to fund inventory
- Seasonal QoQ fluctuations in jewellery demand
Key Highlights
Q1 FY27 Revenue from operations reached INR 4,311 Mn (₹431.1 cr), up 39.0% YoY
EBITDA grew 33.9% YoY to INR 387 Mn with an EBITDA margin of 8.98% (down 34 bps YoY)
PAT reached INR 268 Mn (₹26.8 cr), up 27.0% YoY with a margin of 6.22%
Total processing & job work volume stood at 518 Kgs for the quarter
Setting up a 6,696 sq ft in-house manufacturing facility in Hyderabad to reduce karigar dependency and improve margins
👀 What to Watch
Track the ramp-up and operational margins of the new Hyderabad manufacturing facility, alongside upcoming regional sales office openings in Chennai, Bangalore, and Coimbatore.
Deepak Nitrite Subsidiary Commissions Rs 300 Cr Chlorination & Specialty Plant in Dahej
Deepak Nitrite's wholly owned subsidiary, Deepak Chem Tech Limited, has commissioned manufacturing operations of its Chlorination and Specialty chemical plant along with utilities and infrastructure on September 29, 2026, at Dahej, Gujarat. The total capital expenditure incurred for this project is approximately Rs 300 crore as of the commencement date. This capex represents ~9.3% of the company's net worth (Rs 3,215 crore) and ~3.5% of TTM revenue (Rs 8,575 crore). The facility aligns with the group's strategy to deepen vertical integration into downstream specialty chemicals.
Confidence: HIGH
What changedDeepak Chem Tech Limited commenced commercial manufacturing at its chlorination and specialty chemical plant at Dahej.
Why it mattersAdds higher-margin specialty chemical manufacturing capability, expanding downstream integration and supporting future earnings growth.
Total capex incurred: Rs 300 CroresCapex to Net Worth: ~9.3%Capex to TTM Revenue: ~3.5%Commissioning date: 29th September 2026
📅 Short termPositive sentiment from successful project commissioning without reported delays, though near-term earnings impact depends on ramp-up speed.
📈 Long termEnhances the company's vertical integration and expands the portfolio of higher-value specialty chemicals, mitigating commodity exposure.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Plant ramp-up delays or initial operational bottlenecks
- Exposure to pricing volatility and global demand fluctuations in downstream chemicals
Key Highlights
Deepak Chem Tech Limited commissioned Chlorination and Specialty chemical operations on September 29, 2026
Total capex incurred is approximately Rs 300 crore at commencement
Facility is located at Dahej, District Bharuch, Gujarat, along with necessary utilities and infrastructure
Capex represents ~9.3% of net worth and ~3.5% of TTM revenue
👀 What to Watch
Track the ramp-up schedule and capacity utilization figures in upcoming quarterly updates to gauge revenue and margin contribution from the new specialty facility.
Deepa Jewellers Q1 FY27 Net Profit Rises 27% YoY to ₹267.56 Mn; Revenue Up 39% to ₹4,311.11 Mn
Deepa Jewellers Limited reported its first post-IPO quarterly results for the quarter ended June 30, 2026. Revenue from operations grew 39.0% YoY to ₹4,311.11 million compared to ₹3,100.60 million in Q1 FY26, though it declined sequentially from ₹5,408.54 million in Q4 FY26. Net profit for the period rose 27.0% YoY to ₹267.56 million from ₹210.68 million in Q1 FY26. Basic and diluted EPS stood at ₹3.26 for the quarter on an equity base of ₹164.00 million.
Confidence: HIGH
What changedDeepa Jewellers reported its unaudited financial results for the quarter ended June 30, 2026, marking its maiden quarterly report following its September 2026 stock exchange listing.
Why it mattersDemonstrates solid YoY top-line and bottom-line expansion for the B2B gold jewellery manufacturer, although revenue and profit saw seasonal sequential softening compared to Q4 FY26.
Revenue from operations (Q1 FY27): ₹4,311.11 millionNet profit (Q1 FY27): ₹267.56 millionProfit before tax (Q1 FY27): ₹358.49 millionFresh issue IPO proceeds: ₹2,500 millionBasic & Diluted EPS (Q1 FY27): ₹3.26
📅 Short termThe stock will likely digest the maiden post-listing earnings, reflecting steady YoY growth offset by quarter-on-quarter contraction.
📈 Long termLong-term performance will depend on the effective deployment of the ₹2,500 million fresh issue proceeds into working capital and scaling the B2B hallmarked jewellery business.
⚠ Risk flags
- Sequential contraction in revenue (-20.3% QoQ) and profit
- Working capital intensity inherent to gold jewellery manufacturing
Key Highlights
Revenue from operations grew 39.0% YoY to ₹4,311.11 million (vs ₹3,100.60 million in Q1 FY26)
Net profit increased 27.0% YoY to ₹267.56 million from ₹210.68 million
Profit before tax stood at ₹358.49 million, up 26.5% YoY from ₹283.43 million
Basic and diluted EPS came in at ₹3.26 per share (face value ₹2 each)
Company completed an IPO raising ₹2,500 million via fresh issue and listed on September 08, 2026
👀 What to Watch
Track subsequent quarters to gauge revenue run-rate and observe the deployment timeline of the ₹2,500 million IPO fresh issue proceeds as per the prospectus objectives.
Deepak Fertilisers Bifurcates Manufacturing Leadership; Appoints Amir Alvi as President Operations
Deepak Fertilisers and Petrochemicals Corp. Ltd. has restructured its manufacturing leadership into two distinct roles effective September 1, 2026. Mr. Amir Alvi, who brings over 36 years of industry experience including roles as COO (Fertilizers) at Coromandel International and 23 years at Tata Chemicals, has been appointed as President - Manufacturing Operations (Senior Management Personnel). Concurrently, Mr. Pandurang Landge, previously President - Manufacturing with 44 years of experience, has been redesignated as President - Manufacturing Excellence & Technology Development.
Confidence: HIGH
What changedThe company restructured its manufacturing leadership by creating two distinct positions and appointed ex-Coromandel COO Amir Alvi to lead manufacturing operations from September 1, 2026.
Why it mattersSeparating operational plant management from technology development and excellence strengthens executive bandwidth across Deepak Fertilisers' multi-site operations.
Effective date: 1st September, 2026Amir Alvi industry experience: 36+ yearsPandurang Landge industry experience: 44 yearsAmir Alvi tenure at Tata Chemicals: 23 years
📅 Short termNeutral impact on stock price and near-term financials; represents an orderly management restructuring.
📈 Long termStrengthens manufacturing operations and process engineering focus as the company scales its specialty fertiliser and chemical portfolio.
Key Highlights
Appointed Mr. Amir Alvi as President - Manufacturing Operations effective September 1, 2026
Mr. Amir Alvi brings 36+ years of chemical and fertiliser experience, having previously served as COO at Coromandel International and 23 years at Tata Chemicals
Redesignated existing President - Manufacturing, Mr. Pandurang Landge (44 years experience), as President - Manufacturing Excellence & Technology Development effective September 1, 2026
Manufacturing leadership bifurcated into two separate focus areas: Operations vs Excellence & Technology Development
👀 What to Watch
Track operational execution and manufacturing efficiency gains in upcoming quarters as new leadership assumes operational responsibilities.
Deepak Nitrite and DPL Infuse ₹175 Cr in Subsidiary Deepak Chem Tech via 9% OCRPS
Deepak Nitrite Limited (DNL) and its wholly owned subsidiary Deepak Phenolics Limited (DPL) have infused a total of ₹175 Crore into Deepak Chem Tech Limited (DCTL) via 9% Optionally Convertible Redeemable Preference Shares (OCRPS). DNL subscribed to 80 lakh shares (₹80 Crore) while DPL subscribed to 95 lakh shares (₹95 Crore) at ₹100 par value. The capital will support DCTL's ongoing project expenses and general corporate purposes across its chemical plants in Gujarat. DCTL has scaled its turnover rapidly from ₹0.86 Crore in FY24 to ₹172.23 Crore in FY26.
Confidence: HIGH
What changedDNL and DPL completed an internal capital infusion of ₹175 Crore into wholly owned subsidiary DCTL via 9% OCRPS.
Why it mattersProvides necessary funding to scale DCTL's specialty downstream projects without increasing consolidated external debt.
Total Infusion Amount: ₹175 CroresDNL Direct Infusion: ₹80 CroresDPL Infusion: ₹95 CroresDCTL FY26 Turnover: ₹172.23 CroresInfusion vs TTM Revenue: ~2.0%
📅 Short termNeutral; this is an internal group restructuring/funding event with no immediate impact on consolidated quarterly earnings.
📈 Long termSupports DNL's strategic vertical integration into advanced intermediates and downstream chemistries to diversify away from commodity cycles.
⚠ Risk flags
- Project execution timelines and ramp-up risks at DCTL's Gujarat manufacturing sites.
Key Highlights
DNL and DPL infused ₹80 Crore and ₹95 Crore respectively, totaling ₹175 Crore into DCTL.
Allotment consists of 1.75 Crore 9% OCRPS with a face value of ₹100 each issued at par.
DCTL turnover grew to ₹172.23 Crore in FY26, up from ₹9.43 Crore in FY25 and ₹0.86 Crore in FY24.
Pre-allotment paid-up capital of DCTL stood at ₹2,744.5 Crore (₹499.5 Crore equity and ₹2,245 Crore preference shares).
👀 What to Watch
Track the commercialization and revenue ramp-up of DCTL's fluorination, nitric acid, nitration, and hydrogenation projects in upcoming quarterly updates.
₹2,592 Cr Revenue: Deepak Nitrite Reports Record Q1 FY27 Performance and New Project Commissioning
Deepak Nitrite reported a record-breaking Q1 FY27 with consolidated revenue of ₹2,592 crore, a 35% YoY increase. EBITDA margins expanded significantly to 21% from 11% a year ago, leading to a 207% YoY surge in PAT to ₹345 crore. The company is successfully transitioning into an integrated nitrogen platform, with the ammonia-to-amines integration complete. Management confirmed that MIBK, MIBC, and Acetophenone projects are scheduled for commissioning in August 2026, which will further deepen downstream integration.
Confidence: HIGH
What changedDeepak Nitrite has transitioned from a nitration-focused company to an integrated nitrogen platform and is now moving into high-value downstream products like MIBK and MIBC.
Why it mattersThe shift towards downstream integration and the upcoming Polycarbonate project reduces reliance on commodity chemical cycles and improves structural cost competitiveness against global imports.
Q1 FY27 Revenue: ₹2,592 crQ1 PAT vs TTM PAT: 62.6%EBITDA Margin: 21%Phenolics EBIT Growth (YoY): 254%Advanced Intermediates Revenue: ₹804 cr
📅 Short termThe stock is likely to react positively to the record earnings and the immediate catalyst of new plant commissionings in August 2026.
📈 Long termThe company's strategy to build an integrated advanced material platform, including India's first integrated Polycarbonate project, positions it for structural growth and margin resilience over the next 3-5 years.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Global oversupply and dumping by Asian producers
- Volatility in feedstock prices (Propylene and Benzene)
- Execution risk for large-scale greenfield projects
Key Highlights
Consolidated Revenue reached ₹2,592 crore, up 35% YoY and 22% sequentially.
EBITDA hit an all-time high of ₹554 crore, with margins expanding to 21% from 11% in the previous year.
PAT for Q1 FY27 stood at ₹345 crore, which is approximately 62.6% of the total TTM PAT of ₹551 crore.
Phenolics segment delivered record EBIT of ₹418 crore, a 254% increase YoY.
Commissioning of MIBK, MIBC, and Acetophenone projects confirmed for August 2026.
👀 What to Watch
Investors should monitor the successful ramp-up of the MIBK and MIBC plants in Q2 FY27 and track the execution milestones of the large-scale Polycarbonate project. The sustainability of the 21% EBITDA margin amidst global chemical price volatility is a key metric to watch in upcoming quarters.
₹735 Cr Capex: Deepak Nitrite Commissions MIBK & MIBC Plant at Dahej
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has commissioned its Methyl Isobutyl Ketone (MIBK) and Methyl Isobutyl Carbinol (MIBC) plant at Dahej, Gujarat. The project involved a capital expenditure of approximately ₹735 Crores, which represents about 22.8% of the company's current net worth (₹3,215 Cr). This commissioning marks a significant move into downstream specialty chemicals, aiming to diversify the product mix and improve margin resilience against global dumping. The plant includes necessary offsite utilities and infrastructure, transitioning the project from the investment phase to the revenue-generation phase.
Confidence: HIGH
What changedThe company has successfully completed and commissioned a major ₹735 Cr downstream expansion project, moving from construction to production.
Why it mattersThis expansion into MIBK and MIBC reduces reliance on commodity chemicals and provides a hedge against global dumping by moving further down the value chain into specialty applications.
Project Capex: ₹735 CroresCapex vs Net Worth: ~22.8%Capex vs TTM Revenue: ~9.3%Commissioning Date: August 6, 2026
📅 Short termPositive sentiment is expected as the project begins contributing to the top line, potentially improving the revenue run rate from Q3 FY27 onwards.
📈 Long termStructurally significant as it strengthens the company's 'China+1' positioning and vertical integration, creating higher entry barriers in the specialty chemicals segment.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Ramp-up execution risk
- Global oversupply leading to pricing pressure
- Raw material price volatility
Key Highlights
Commissioned manufacturing operations for MIBK and MIBC at Dahej on August 6, 2026
Total capital expenditure incurred for the project is approximately ₹735 Crores
Capex represents ~9.3% of the company's TTM revenue of ₹7,887 Crores
Project executed through 100% subsidiary Deepak Chem Tech Limited
Includes integrated offsite utilities and infrastructure for the new facility
👀 What to Watch
Monitor the capacity utilization ramp-up and the resulting impact on consolidated operating margins (OPM) in the next 2-3 quarters. Investors should also watch for management commentary regarding domestic market share gains against imported MIBK/MIBC.
101% PAT Growth in Q1 FY27; Major TAN and Acid Projects Near Completion
DEEPAKFERT reported its historic best Q1 FY27 results, with PAT doubling to ₹490 cr and revenue growing 22% YoY to ₹3,256 cr. The performance was driven by strong realizations in Technical Ammonium Nitrate (TAN) and Nitric Acid, alongside benefits from the integrated gas-to-ammonia value chain. Net debt leverage improved significantly to 1.4x from 2.86x. Two major capex projects—TAN at Gopalpur (96% complete) and Acids at Dahej (93% complete)—are nearing commissioning, which is expected to drive H2 growth.
Confidence: HIGH
What changedThe company has transitioned from a heavy capex phase to a realization phase, delivering record quarterly profits while nearing the completion of two major expansion projects.
Why it mattersThe integration of the ammonia value chain and the shift toward specialty/B2C products are structurally improving margins and reducing debt, providing resilience against commodity volatility.
Q1 FY27 Revenue: ₹3,256 crQ1 PAT Growth (YoY): 101%EBITDA Margin: 26%Net Debt/EBITDA: 1.4xGopalpur Project Completion: 96%Ammonia Price (FOB ME): $600
📅 Short termPositive sentiment is expected due to the record earnings and debt reduction, although Q2 may see a seasonal slowdown in mining volumes due to monsoons.
📈 Long termStructural growth is supported by the completion of the TAN and Acid projects, which will expand capacity and improve margins through backward integration and specialty product focus.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Volatility in raw material prices (Ammonia, Phos Acid)
- Geopolitical disruptions in the Middle East and Russia
- Monsoon impact on mining and fertilizer demand
Key Highlights
Q1 FY27 PAT doubled YoY to ₹490 cr, achieving 65% of the total FY26 full-year profit in a single quarter.
Operating EBITDA jumped 65% YoY to ₹845 cr, with margins expanding to 26% from 19% in the previous year.
TAN Gopalpur project is 96% complete and Dahej Acids project is 93% complete, both nearing H2 FY27 commissioning.
Net debt to EBITDA ratio improved significantly to 1.4x from 2.86x, reflecting strong cash generation.
B2C revenue in the mining chemicals segment grew 42% YoY to ₹151 cr, now contributing 17% of segment revenue.
👀 What to Watch
Monitor the commissioning and capacity ramp-up of the Gopalpur and Dahej facilities in H2 FY27. Investors should also track global ammonia prices (currently ~$600/ton) and potential Russian export bans on FGAN which could impact realizations.
Deepak Nitrite Approves ₹7.50 Dividend and Key Leadership Elevations at 55th AGM
Deepak Nitrite concluded its 55th Annual General Meeting on August 5, 2026, where shareholders approved a dividend of ₹7.50 per share (375% of face value) for FY26. The meeting formalized significant leadership transitions, including the elevation of Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms. Additionally, Anant Pande was appointed as Executive Director & CMO, and Sanjay Upadhyay was re-appointed as Group CFO for another 5 years. These moves solidify the management structure as the company pursues its integrated Polycarbonate and downstream chemical projects.
Confidence: HIGH
What changedThe company has transitioned its leadership team with new Deputy MD roles and a dedicated CMO, while confirming the FY26 dividend payout.
Why it mattersManagement continuity and a clear leadership hierarchy are critical as the company manages a ₹23,720 Cr market cap and navigates global oversupply challenges in the chemical sector.
Dividend per share: ₹7.50Dividend % of Face Value: 375%Deputy MD Appointment Term: 5 yearsEstimated Dividend Payout: ~₹102 CrDividend vs TTM PAT: ~18.5%
📅 Short termThe stock is likely to react neutrally as the AGM proceedings and dividend were largely anticipated by the market.
📈 Long termThe 5-year mandates for the Deputy MDs and CFO provide structural stability for the company's long-term shift toward high-margin downstream products.
⚠ Risk flags
- Promoter remuneration levels (Special Resolution)
- Global oversupply impacting domestic margins
Key Highlights
Approved a dividend of ₹7.50 per equity share of ₹2.00 face value (375%) for FY26
Elevated Mautik Mehta and Meghav Mehta to Deputy Managing Directors for 5-year terms starting May 9, 2026
Appointed Anant Pande as Executive Director & CMO for a 3-year term effective August 5, 2026
Re-appointed Sanjay Upadhyay as Director (Finance) & Group CFO for a 5-year term from August 1, 2026
Approved the appointment of two new Independent Directors, Mitin Mehta and Adnan Ahmad, for 3-year terms
👀 What to Watch
Investors should monitor the final voting results to check for any significant dissent on promoter remuneration (Resolution 13). The focus remains on the execution timeline of the upcoming Polycarbonate and MIBK/MIBC projects mentioned in the company's growth strategy.
207% PAT Growth: Deepak Nitrite Reports Highest-Ever Quarterly Performance in Q1 FY27
Deepak Nitrite delivered a record-breaking Q1 FY27, with consolidated revenue growing 35% YoY to 2,592 Cr. Profitability saw a massive surge as PAT rose 207% YoY to 345 Cr, driven by a 254% EBIT jump in the Phenolics segment. The company is aggressively pursuing its 2,900 Cr Polycarbonate project, with equipment shipments from Germany already arriving at the Dahej site. EBITDA margins expanded significantly to 21.4% from 11.2% in the year-ago period, reflecting strong operational leverage.
Confidence: HIGH
What changedThe company has achieved a significant margin breakout, with EBITDA growing 159% YoY, moving past the margin compression seen in FY26.
Why it mattersThe record performance validates the company's vertical integration strategy and its ability to maintain high operating rates (Phenolics) despite global chemical industry volatility.
Q1 FY27 Revenue: 2,592 CrQ1 FY27 PAT: 345 CrPolycarbonate Project Commitment: 2,900 CrProject vs Market Cap: ~12.4%EBITDA Margin: 21.4%
📅 Short termThe stock is likely to react positively to the substantial earnings beat and the 'highest-ever' quarterly performance milestone.
📈 Long termStructural growth is underpinned by the 2,900 Cr downstream expansion into Polycarbonates, which aims to substitute imports and deepen the value chain.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Geopolitical tensions affecting logistics costs
- Pricing uncertainty in chemical intermediates
- Execution risk for the large-scale Polycarbonate project
Key Highlights
Highest-ever quarterly revenue of 2,592 Cr, up 35% YoY and 22% QoQ
PAT surged 207% YoY to 345 Cr, significantly exceeding the TTM average quarterly run rate
Phenolics segment EBIT grew 254% YoY to 418 Cr, supported by favorable product spreads
Total financial commitment for the integrated Polycarbonate project reached 2,900 Cr
Renewable energy initiatives delivered 4.5 Cr in cost savings during the quarter
👀 What to Watch
Watch for the execution timeline of the 165,000 MT/yr Polycarbonate plant and the impact of the 15-year Petronet LNG agreement on long-term feedstock cost stability.
Rs 2,500 Cr Investment: Deepak Nitrite to Set Up 240 KTA Bisphenol A Plant
Deepak Nitrite's subsidiary, Deepak Chem Tech Limited (DCTL), has approved a major investment of approximately Rs 2,500 crore to establish a Bisphenol A (BPA) manufacturing plant. The project features a capacity of up to 240 KTA and includes greenfield infrastructure. This investment is highly significant, representing roughly 31.7% of the company's TTM revenue and 77.8% of its current net worth. The move completes a strategic value chain from Phenol/Acetone to Polycarbonate, aiming to capture growth in the Indian Epoxy resin market and captive requirements.
Confidence: HIGH
What changedDeepak Nitrite has formally committed to a large-scale downstream expansion into Bisphenol A, moving beyond its existing Phenolics business.
Why it mattersThis project creates a highly integrated chemical platform, reducing raw material risks for their upcoming Polycarbonate plant and entering the high-demand Epoxy resin market, which currently relies on imports.
Project Investment: Rs 2,500 CrCapacity: 240 KTAInvestment vs TTM Revenue: ~31.7%Investment vs Net Worth: ~77.8%Current Debt: Rs 60 Cr
📅 Short termThe market is likely to react positively to the scale of the expansion and the strategic move towards higher-value integrated products.
📈 Long termIf executed successfully, this transforms Deepak Nitrite into a dominant integrated player in the BPA-Polycarbonate chain, potentially improving long-term margins and market share.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution risk of a large-scale greenfield project
- Significant increase in debt levels
- Cyclicality of the Phenol-Acetone-BPA value chain
Key Highlights
Approved investment of approximately Rs 2,500 Crores for a new manufacturing complex.
Planned production capacity of up to 240 KTA for Bisphenol A (BPA).
Investment magnitude represents ~31.7% of TTM revenue (Rs 7,887 Cr).
Project to be funded through a mix of debt and equity, impacting the current low debt of Rs 60 Cr.
Enables a fully integrated value chain from Cumene to Polycarbonate resin.
👀 What to Watch
Watch for the finalization of detailed engineering and the specific debt-equity funding mix, as this will significantly alter the company's leverage profile from its current near-debt-free status.
Deepak Nitrite Appoints Lohit Shringi as CEO for Advanced Intermediates Business
Deepak Nitrite has appointed Shri Lohit Shringi as the Chief Executive Officer for its Advanced Intermediates (AI) business, effective August 4, 2026. Shringi brings over 27 years of experience, having previously served as Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited. This leadership addition is strategic as the AI segment is currently undergoing both brownfield and greenfield expansions to deepen vertical integration. Given the company's TTM revenue of ‡7,887 Cr and current margin pressures from global dumping, this appointment aims to strengthen P&L management in a core growth area.
Confidence: HIGH
What changedThe company has transitioned the leadership of its Advanced Intermediates business to a dedicated CEO with extensive specialty chemicals experience.
Why it mattersThe Advanced Intermediates segment is central to Deepak Nitrite's 'China+1' strategy and downstream integration; professional leadership is vital to navigate current global oversupply and pricing challenges.
Leadership Experience: 27 yearsEffective Date: August 4, 2026TTM Revenue: ‡7,887 CrMarket Cap: ‡23,461 Cr
📅 Short termThe market is likely to view the addition of a seasoned industry veteran from PCBL and DuPont as a positive step for operational stability.
📈 Long termShringi's experience in specialty chemicals and global markets is structurally significant for the company's move into high-value downstream products like MIBK and Polycarbonates.
⚠ Risk flags
- Execution risk in ongoing greenfield projects
- Global oversupply impacting AI segment margins
Key Highlights
Shri Lohit Shringi appointed as CEO of Advanced Intermediates Business effective August 4, 2026.
Shringi brings over 27 years of leadership experience across P&L management and business transformation.
Previously held the role of Executive Director and Chief of Specialty Chemicals at PCBL Chemical Limited.
The AI segment is a critical driver for the company's ‡7,887 Cr TTM revenue base.
Appointment coincides with ongoing greenfield and brownfield expansions in the AI segment via DCTL.
👀 What to Watch
Investors should monitor the execution of the AI segment's expansion projects and margin recovery in upcoming quarterly results under the new leadership.
Deepak Nitrite Q1 FY27: Consolidated PAT Surges 207% YoY to ₹344.7 Cr
Deepak Nitrite reported a robust Q1 FY27 with consolidated revenue growing 36.4% YoY to ₹2,577.60 Cr. Net profit witnessed a massive jump of 207% YoY to ₹344.69 Cr, primarily driven by a sharp recovery in the Phenolics segment. The Phenolics segment EBIT rose 254% YoY to ₹417.76 Cr, while the Advanced Intermediates segment also grew revenue by 32.8% YoY. This performance represents a significant recovery from the margin pressures seen in previous quarters.
Confidence: HIGH
What changedDeepak Nitrite has reported a sharp turnaround in profitability for Q1 FY27, moving past the dumping-related margin compression seen in FY25/FY26.
Why it mattersThe strong performance in the Phenolics segment indicates improved domestic demand and better realization, providing the necessary cash flow for the company's massive downstream expansion plans.
Consolidated Revenue (Q1 FY27): ₹2,577.60 CrConsolidated PAT (Q1 FY27): ₹344.69 CrYoY PAT Growth: 207.1%Phenolics EBIT Margin: 23.5%Advanced Intermediates Revenue Growth: 32.8%
📅 Short termThe stock is likely to react positively in the short term due to the significant earnings beat and margin expansion in the Phenolics business.
📈 Long termThe long-term outlook remains tied to the successful operationalization of MIBK, MIBC, and the landmark Polycarbonate project, which will deepen vertical integration.
⚠ Risk flags
- Global oversupply and dumping by Asian producers
- Volatility in raw material and energy costs
- Execution risk on large-scale greenfield projects
Key Highlights
Consolidated Revenue from operations increased 36.4% YoY to ₹2,577.60 Cr from ₹1,889.88 Cr.
Consolidated Net Profit grew 207.1% YoY to ₹344.69 Cr compared to ₹112.25 Cr in the same quarter last year.
Phenolics segment EBIT jumped to ₹417.76 Cr from ₹117.90 Cr YoY, reflecting strong operating leverage.
Advanced Intermediates revenue grew to ₹803.85 Cr from ₹605.33 Cr in the year-ago period.
Government incentive income of ₹21.50 Cr was recognized during the quarter.
👀 What to Watch
Investors should monitor the sustainability of Phenolics margins and the execution timeline of the upcoming Polycarbonate project, which is key to long-term value creation.
Deepak Fertilizers Q1 FY27 Standalone PAT at ₹68.34 Cr; Tax Auditor Re-appointed
Deepak Fertilizers' board approved Q1 FY27 results and the re-appointment of M/s P G Bhagwat LLP as Tax Auditors for FY 2026-27. Standalone revenue for the quarter was ₹516.97 Cr, representing an 11.4% decline from ₹583.66 Cr in Q1 FY26. Standalone PAT also saw a contraction, falling 21.3% YoY to ₹68.34 Cr. The company continues its strategic focus on specialty products, which currently contribute 35% to fertilizer revenue.
Confidence: HIGH
What changedThe company has formally approved its Q1 FY27 financial results and re-appointed its existing tax auditor for the new financial year.
Why it mattersThe standalone results show a year-on-year contraction in both revenue and profit, which may reflect the geopolitical headwinds and margin pressures previously flagged by management.
Standalone Revenue (Q1 FY27): ₹516.97 CrStandalone PAT (Q1 FY27): ₹68.34 CrYoY Revenue Change (Standalone): -11.4%YoY PAT Change (Standalone): -21.3%Standalone Basic EPS: ₹5.41
📅 Short termThe standalone earnings contraction might lead to neutral or slightly cautious sentiment in the immediate term until consolidated performance is fully assessed.
📈 Long termStructural growth remains tied to the shift toward high-margin specialty chemicals and the full capacity realization of new projects expected by FY 2029.
⚠ Risk flags
- Margin pressure from geopolitical trade barriers
- Dependency on global ammonia supply during Q4 shutdowns
Key Highlights
Standalone Revenue for Q1 FY27 reported at ₹516.97 Cr, down from ₹583.66 Cr YoY
Standalone Net Profit for the quarter ended June 30, 2026, stood at ₹68.34 Cr
Standalone Basic and Diluted EPS for Q1 FY27 recorded at ₹5.41
Re-appointment of M/s P G Bhagwat LLP as Tax Auditors for the financial year 2026-27
Total Standalone Expenses for the quarter were ₹439.02 Cr compared to ₹494.89 Cr in Q1 FY26
👀 What to Watch
Investors should monitor the consolidated results to see if the specialty product mix (Croptek at 35% of fertilizer revenue) is successfully offsetting the margin pressure seen in the standalone figures.
101% YoY PAT Growth in Q1 FY27; ₹1,983 Cr Nitric Acid Project Commissioning in Q2
DEEPAKFERT reported a robust Q1 FY27 with PAT doubling YoY to ₹490 Cr, driven by a 22% revenue increase to ₹3,256 Cr. Operating EBITDA margins expanded significantly to 26.0% from 19.3% in the previous year, supported by global supply tightness and improved realizations in Mining Chemicals. The company is on the verge of commissioning its ₹1,983 Cr Nitric Acid project in Dahej during Q2 FY27, which will establish it as Asia's largest manufacturer. Despite a quarterly capex of ₹515 Cr, net debt reduced to ₹4,719 Cr, reflecting strong operational cash flows.
Confidence: HIGH
What changedThe company has achieved a significant turnaround in profitability and margins, moving from a 12% EBITDA margin in Q4 FY26 to 26% in Q1 FY27, while nearing the completion of a major capex cycle.
Why it mattersThe doubling of profits and the imminent launch of Asia's largest Nitric Acid facility signal a transition toward higher-margin specialty products and market dominance in industrial chemicals.
Q1 FY27 PAT Growth (YoY): 101%Operating EBITDA Margin: 26.0%Dahej Project Capex: ₹1,983 CrCapex vs Net Worth: 54.1%Net Debt: ₹4,719 CrQ1 FY27 Revenue: ₹3,256 Cr
📅 Short termThe stock is likely to react positively to the sharp earnings beat and the clear timeline for the Dahej project commissioning.
📈 Long termThe structural shift from commodity to specialty chemicals (now 43% of fertilizer revenue) and massive capacity additions in Nitric Acid and TAN provide a strong multi-year growth trajectory.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Regulatory disruptions (PESO ANRS portal changes)
- Geopolitical risks affecting raw material supply (RGP curtailment)
- Monsoon-dependent demand for fertilizers
Key Highlights
Consolidated PAT surged 101% YoY to ₹490 Cr, while Revenue grew 22% YoY to ₹3,256 Cr.
Operating EBITDA margins improved to 26.0% in Q1 FY27 compared to 19.3% in Q1 FY26.
Mining Chemicals (TAN) revenue grew 36% YoY, with B2C revenue contributing ₹151 Cr (17% of segment).
The ₹1,983 Cr Nitric Acid project in Dahej is scheduled for commissioning in Q2 FY27.
Net Debt/EBITDA improved significantly to 1.40x as of June 2026 from 2.86x in March 2026.
👀 What to Watch
Investors should monitor the successful commissioning and capacity ramp-up of the Dahej Nitric Acid project in Q2 FY27. Additionally, track the impact of monsoon progress on the Crop Nutrition segment's performance in the upcoming quarter.
Q1 FY27 Standalone Net Profit Falls 21.3% YoY to ₹68.34 Cr
Deepak Fertilizers reported a weak standalone performance for Q1 FY27, with revenue declining 11.4% YoY to ₹516.97 Cr. Net profit followed suit, dropping 21.3% YoY to ₹68.34 Cr, while EPS decreased to ₹5.41 from ₹6.88. A significant cash flow hedge loss of ₹46.91 Cr (pre-tax) further impacted the total comprehensive income. The company continues to focus on its long-term transition toward specialty products and is progressing with major projects in Dahej and Gopalpur.
Confidence: HIGH
What changedThe company reported its standalone financial results for the first quarter of FY27, showing a contraction in both revenue and profitability compared to the same period last year.
Why it mattersThe standalone results reflect pressure on the core entity's margins and volumes; however, the company's overall valuation is heavily tied to its consolidated performance and the shift toward high-margin specialty chemicals.
Standalone Revenue (Q1 FY27): ₹516.97 CrStandalone Net Profit (Q1 FY27): ₹68.34 CrYoY Revenue Growth: -11.4%YoY Net Profit Growth: -21.3%Cash Flow Hedge Loss (Pre-tax): ₹46.91 Cr
📅 Short termThe stock may experience short-term pressure due to the YoY decline in standalone earnings and the impact of hedge losses on comprehensive income.
📈 Long termThe long-term outlook remains tied to the successful commissioning of new capacities by FY2029 and the increasing contribution of specialty products like Croptek, which currently accounts for 35% of fertilizer revenue.
⚠ Risk flags
- Volatility in raw material prices
- Significant losses in cash flow hedges impacting comprehensive income
- Geopolitical risks affecting EBITDA margins
Key Highlights
Standalone Revenue from operations fell to ₹516.97 Cr in Q1 FY27 from ₹583.66 Cr in Q1 FY26.
Net Profit after tax declined to ₹68.34 Cr, down from ₹86.85 Cr in the corresponding quarter of the previous year.
Total expenses decreased by 11.3% YoY to ₹439.02 Cr, primarily due to lower material consumption costs.
Other Comprehensive Income recorded a net loss of ₹35.04 Cr, largely driven by a ₹46.91 Cr loss on cash flow hedges.
The company confirmed ongoing progress on the Nitric Acid project in Dahej and the TAN project in Gopalpur.
👀 What to Watch
Investors should monitor the consolidated results for a complete picture of the group's performance and track the execution timeline of the Dahej and Gopalpur projects, which are critical for long-term growth.
Q1 Standalone Net Profit Drops 21% YoY to ₹68.34 Cr; Revenue Down 11%
Deepak Fertilizers reported a weak start to FY27 on a standalone basis, with revenue from operations declining 11.4% YoY to ₹516.97 Cr. Net profit followed suit, dropping 21.3% YoY to ₹68.34 Cr from ₹86.85 Cr in the year-ago period. Standalone EPS for the quarter contracted to ₹5.41 compared to ₹6.88 in Q1 FY26. The board also confirmed the re-appointment of M/s P G Bhagwat LLP as Tax Auditors for the 2026-27 fiscal year.
Confidence: HIGH
What changedThe company released its Q1 FY27 financial results, marking a year-on-year decline in standalone top-line and bottom-line performance.
Why it mattersThe standalone results reflect the core manufacturing operations; a double-digit decline in profit suggests ongoing margin pressure or volume contraction in industrial chemicals and fertilizers, despite the company's strategic shift toward specialty products.
Standalone Revenue (Q1 FY27): ₹516.97 CrStandalone Net Profit (Q1 FY27): ₹68.34 CrYoY Revenue Growth (Standalone): -11.4%Standalone EPS: ₹5.41Standalone Q1 Revenue vs TTM Revenue: 4.5%
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the YoY decline in standalone profitability.
📈 Long termThe long-term outlook remains tied to the successful ramp-up of specialty products (Croptek) and the realization of capacity from new projects by FY 2029, aiming for a 20% plus ROCE.
⚠ Risk flags
- Margin contraction in standalone operations
- Geopolitical headwinds affecting global chemical markets
- Significant negative impact from cash flow hedges in the current quarter
Key Highlights
Standalone Revenue from operations fell to ₹516.97 Cr in Q1 FY27 from ₹583.66 Cr in Q1 FY26
Standalone Net Profit after tax decreased by 21.3% YoY to ₹68.34 Cr
Total standalone expenses reduced to ₹439.02 Cr from ₹494.89 Cr, largely due to lower material consumption costs
Standalone Basic and Diluted EPS stood at ₹5.41 for the quarter, down from ₹6.88 YoY
Other Comprehensive Income showed a significant loss of ₹35.04 Cr, primarily due to cash flow hedge adjustments
👀 What to Watch
Investors should monitor the full consolidated results to assess if subsidiary performance mitigated the standalone decline. Key focus areas include the execution timeline for the Dahej and Gopalpur projects and the impact of global ammonia price volatility on margins.
₹120 Cr Investment in Deepak Chem Tech by Deepak Phenolics for Project Funding
Deepak Nitrite's subsidiary, Deepak Phenolics Limited (DPL), has invested ₹120 crore in another wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL). The investment is made through 9% Optionally Convertible Redeemable Preference Shares (OCRPS) to support DCTL's project expenses and strengthen its capital base. DCTL is scaling rapidly, with its turnover increasing from ₹9.43 crore in FY25 to ₹172.23 crore in FY26. This internal capital reallocation supports the group's expansion into specialized segments like Fluorination and Nitric Acid.
Confidence: HIGH
What changedDeepak Nitrite has moved ₹120 crore of capital from its Phenolics subsidiary to its Chem Tech subsidiary to fund ongoing specialized chemical projects.
Why it mattersThis demonstrates the company's strategy of using cash flows from its established Phenolics business to fund high-growth, downstream specialized chemical segments without external debt.
Investment Amount: ₹120.00 CroresDCTL FY26 Turnover: ₹172.23 CroresInvestment vs Net Worth: ~3.7%OCRPS Coupon Rate: 9%DCTL FY25 Turnover: ₹9.43 Crores
📅 Short termNeutral, as this is an intra-group transaction with no immediate impact on consolidated financial performance.
📈 Long termPositive, as it facilitates the expansion of DCTL's specialized chemical portfolio, which is central to the company's long-term 'China+1' and import substitution strategy.
⚠ Risk flags
- Execution risk of ongoing projects within DCTL
- Cyclicality and global dumping risks in the chemical sector
Key Highlights
₹120 crore total investment through the allotment of 1,20,00,000 OCRPS at ₹100 each
DCTL turnover grew significantly to ₹172.23 crore in FY26 from just ₹9.43 crore in FY25
The 9% OCRPS are issued at par and represent an intra-group transaction on an arm's length basis
DCTL currently operates plants for Fluorination, Nitric Acid, Nitration, and Hydrogenation in Gujarat
Deepak Nitrite continues to maintain 100% indirect control over DCTL's preference share capital
👀 What to Watch
Investors should monitor the operational ramp-up and margin profile of Deepak Chem Tech (DCTL) as it transitions from a project-phase entity to a meaningful revenue contributor.
$78.43 Million Corporate Guarantee Issued for Oman Subsidiary
Deepak Nitrite Limited has executed a Deed of Guarantee for US $78.43 million (approximately ₹655 crore) in favor of Bank Muscat SAOG. This guarantee secures a term loan for its 51% subsidiary, Deepak Oman Industries (SFZ) LLC (DOIL). The remaining 49% of DOIL is held by promoter entities, and the company will charge a guarantee commission for this service. This commitment represents a significant contingent liability, equivalent to approximately 20.4% of the company's current net worth.
Confidence: HIGH
What changedDeepak Nitrite has formally committed to backing a $78.43M loan for its Oman-based subsidiary, creating a new contingent liability.
Why it mattersThis move facilitates capital for the company's international expansion in Oman but links the parent company's balance sheet to the subsidiary's financial performance.
Guarantee Amount: US $78.43 MillionSubsidiary Ownership: 51%Guarantee vs Net Worth: ~20.4%Guarantee vs TTM Revenue: ~8.3%Parent Net Worth: ₹3,215 Cr
📅 Short termThe market is likely to view this as a routine support for a subsidiary, though the size of the contingent liability may be noted by analysts.
📈 Long termThe structural impact depends on the successful execution and profitability of the Oman project; failure there could impact the parent's credit profile.
⚠ Risk flags
- Contingent liability risk
- Related-party involvement (Promoters hold 49% of the subsidiary)
Key Highlights
Corporate guarantee of US $78.43 Million issued to Bank Muscat SAOG.
Guarantee supports a term loan for 51% subsidiary Deepak Oman Industries (SFZ) LLC.
Remaining 49% equity in the subsidiary is held by Promoter/Promoter entities.
The guarantee amount of ~₹655 crore represents 20.4% of the company's net worth of ₹3,215 crore.
The transaction is on an arm's length basis with a guarantee commission to be charged.
👀 What to Watch
Investors should monitor the operational progress and debt-servicing capability of the Oman subsidiary to ensure the guarantee is not invoked.
Deepak Fertilizers Invests ₹5 Crore for 26% Stake in First Energy 11 for Captive Power
Deepak Fertilizers and Petrochemicals Corporation Limited has completed an investment of ₹5,00,00,000 in First Energy 11 Private Limited. The company has been allotted 50,00,000 equity shares, representing a minimum 26% stake (along with other captive users). This strategic move is intended for wind-solar hybrid power captive consumption to optimize energy costs under the Electricity Act, 2003. The shares were officially credited to the company's demat account on June 16, 2026.
Key Highlights
Invested ₹5,00,00,000 for the subscription of 50,00,000 equity shares at ₹10 each.
Acquired a minimum 26% stake in First Energy 11 Private Limited for captive power purposes.
The investment facilitates access to Wind-Solar Hybrid Power, aiming to reduce long-term energy costs.
The transaction follows a Share Subscription and Shareholders Agreement (SSSA) originally signed on March 20, 2026.
Shares were credited to the company's demat account on June 16, 2026, finalizing the investment process.
👀 What to Watch
Investors should view this as a positive step toward operational efficiency and ESG compliance; monitor future earnings for improvements in power and fuel cost margins.
